ARKG

ARK Genomic Revolution Multi-Sector ETF

Up$31.11
+$0.26
(+0.84%)
As of 9:00:00 PM EDT | 11/12/19  |  Market Closed

ARKG Trading Data

Open

$30.99

Low Price

$30.77

High Price

$31.39

Previous Last Price

$30.85

Bid Size

$0 X 0

Ask Size

$0 X 0

ARKG Portfolio Data

AUM

$413,008,100

Shares

13,405

PE Ratio

0

Price / Book Ratio

4.72

Expense Ratio

0.75

Net Asset Value

$30.81

Volume

Volume

79,557

Avg. Volume (YDT)

131,017

Dollar Volume

$2,473,199

Weekly Avg. Volume

91,560

Monthly Avg. Volume

99,520

Quarterly Avg. Volume

95,162

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Technicals

Alpha

1

Beta

1.93

Leverage

Long

Standard Deviation

2.58

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.88

ARKG Performance

YTD Return

29.73%

1 Year Return

8.55%

3 Year Return

65.15%

5 Year Return

54.02%

10 Year Return

53.48%

ARKG Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.